Tissue plasminogen activator promotes white matter integrity and functional recovery in a murine model of traumatic brain injury [Neuroscience]

Recombinant tissue plasminogen activator (tPA) is a Food and Drug Administration-approved thrombolytic treatment for ischemic stroke. tPA is also naturally expressed in glial and neuronal cells of the brain, where it promotes axon outgrowth and synaptic plasticity. However, there are conflicting reports of harmful versus neuroprotective effects of tPA in...

https://ift.tt/2ORSbun